IL82624A - Compositions for co- vaccination comprising bacterial lipopolysaccharides - Google Patents

Compositions for co- vaccination comprising bacterial lipopolysaccharides

Info

Publication number
IL82624A
IL82624A IL82624A IL8262487A IL82624A IL 82624 A IL82624 A IL 82624A IL 82624 A IL82624 A IL 82624A IL 8262487 A IL8262487 A IL 8262487A IL 82624 A IL82624 A IL 82624A
Authority
IL
Israel
Prior art keywords
vaccination
compositions
bacterial lipopolysaccharides
lipopolysaccharides
bacterial
Prior art date
Application number
IL82624A
Other languages
English (en)
Other versions
IL82624A0 (en
Original Assignee
Oread Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oread Pharmaceutical Inc filed Critical Oread Pharmaceutical Inc
Publication of IL82624A0 publication Critical patent/IL82624A0/xx
Publication of IL82624A publication Critical patent/IL82624A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A61K39/1045—Moraxella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL82624A 1986-05-23 1987-05-22 Compositions for co- vaccination comprising bacterial lipopolysaccharides IL82624A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86645186A 1986-05-23 1986-05-23

Publications (2)

Publication Number Publication Date
IL82624A0 IL82624A0 (en) 1987-11-30
IL82624A true IL82624A (en) 1993-02-21

Family

ID=25347657

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82624A IL82624A (en) 1986-05-23 1987-05-22 Compositions for co- vaccination comprising bacterial lipopolysaccharides

Country Status (8)

Country Link
EP (1) EP0367757B1 (xx)
CA (1) CA1305667C (xx)
DE (1) DE3750725T2 (xx)
DK (1) DK174196B1 (xx)
IE (1) IE66690B1 (xx)
IL (1) IL82624A (xx)
WO (1) WO1987007148A1 (xx)
ZA (1) ZA873698B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018627A1 (en) † 1990-05-29 1991-12-12 Smithkline Beecham Corporation Swine pneumonia vaccine and method for the preparation thereof
WO1995029662A2 (en) * 1994-04-20 1995-11-09 U.S. Department Of The Army Vaccine against gram-negative bacterial infections
US6749831B1 (en) 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1085956A (en) * 1963-09-10 1967-10-04 Nat Res Dev Improvements relating to vaccines
US4016253A (en) * 1975-04-02 1977-04-05 Iowa State University Research Foundation, Inc. Vaccine for immunization of swine against Bordetella bronchiseptica infection and method of use
US4167560A (en) * 1977-04-12 1979-09-11 Texas Vet Lab, Inc. Polyvalent shipping fever vaccine
DK138379A (da) * 1979-04-04 1980-10-05 Nordisk Droge & Kemikalie Vaccine imod pleuropneumonia (ondartet lungesyge) hos svin dens anvendelse samt fremgangsmaade og substat til dyrkning specielt aerob fermentering af mikroorganismen haemophilus pleuropneumoniae
IL59663A (en) * 1980-03-19 1983-02-23 Univ Ramot Vaccines obtained from bacterial mutant strains of enterobacteriaceae and pseudomonaceae
US4455142A (en) * 1980-07-07 1984-06-19 Alza Corporation Method of coadministering an antigen and an immunopotentiator
US4428931A (en) * 1982-03-15 1984-01-31 Merck & Co., Inc. Bacterial toxoids and gram-negative immune globulin therefrom
US4469672A (en) * 1983-04-07 1984-09-04 Iowa State University Research Foundation Method of combined parenteral and oral vaccination for swine dysentery
IE940698L (en) * 1984-04-05 1985-10-05 Univ Missouri Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant

Also Published As

Publication number Publication date
DE3750725T2 (de) 1995-06-08
DK174196B1 (da) 2002-09-16
IE66690B1 (en) 1996-01-24
IL82624A0 (en) 1987-11-30
DE3750725D1 (de) 1994-12-08
EP0367757A1 (en) 1990-05-16
DK30788D0 (da) 1988-01-22
WO1987007148A1 (en) 1987-12-03
IE871343L (en) 1987-11-23
DK30788A (da) 1988-01-22
EP0367757B1 (en) 1994-11-02
CA1305667C (en) 1992-07-28
ZA873698B (en) 1987-11-18

Similar Documents

Publication Publication Date Title
GB8615534D0 (en) Composition
GB8623459D0 (en) Composition
GB8724250D0 (en) Composition
ZA871644B (en) Antioxidant compositions
GB8714145D0 (en) Phtoresist composition
PH23749A (en) Composition
GB8607157D0 (en) Lubricating compositions
PH23311A (en) Bacterial composition
GB8721400D0 (en) Composition
GB8612550D0 (en) Composition
GB8622124D0 (en) Composition
PH25886A (en) Namatocidal compositions
GB8607160D0 (en) Disinfecting compositions
IL82624A (en) Compositions for co- vaccination comprising bacterial lipopolysaccharides
AU2042688A (en) Heat-vulcanizable organopolysiloxane compositions
GB8613196D0 (en) Compositions
IL81143A0 (en) Halophor compositions
GB8601048D0 (en) Compositions
GB8724502D0 (en) Polysiloxane compositions
PT86415A (en) Compositions
GB8630713D0 (en) Compositions
GB8706697D0 (en) Composition
HUT46724A (en) Sprinkling-salt composition
GB8607686D0 (en) Compositions
GB8606767D0 (en) Compositions

Legal Events

Date Code Title Description
KB Patent renewed
HP Change in proprietorship
KB Patent renewed
EXP Patent expired